About Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
The Tulane School of Public Health and Tropical Medicine is part of Tulane University, located in New Orleans, in the U.S. state of Louisiana.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
During the past decade, Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
2006-02-01
2011-03-01
Terminated
208
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS"
#1 collaborator was "Chiron Corporation" with 1 trials as a collaborator and "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
According to Clinical.Site data, the most researched conditions in "Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS" are
"HIV Infections" (4 trials). Many other conditions were trialed in "Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS" in a lesser frequency.
Clinical Trials Intervention Types at Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
Most popular intervention types in "Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Antiretroviral Regimens" (1 trials) and "Recombinant interleukin-2 (rIL-2)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
The vast majority of trials in "Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS" are
4 trials for "All" genders.
Clinical Trials Status at Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
Currently, there are NaN active trials in "Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".